European shares rose after bullish data.
The ZEW German economic sentiment indicator jumped 5.7 points in
August to 42 points, the highest level since March. Analysts had
expected a reading of 39.1, according to FactSet.
Consumer price inflation accelerated for the third straight
month, to 1.9% in July from 1.8% in June, the statistics office
said, confirming a preliminary estimate from July 30. By
comparison, annual inflation was just 1.2% in April.
In the UK, the Royal Institute of Chartered Surveyors said its
house prices balance rose to +36 in July from +21 the previous
month, and was the highest since November 2006, when it reached
+42. The reading marked the fastest pace of price increases in more
than six years with demand for homes at a four-year peak.
In the United States, retail sales rose 0.2% in July, just off
expectations for up 0.3%, according to Marketwatch.com. Excluding
the 1.0% drop in motor vehicle sales, however, retail sales rose
0.5%, ahead of expectations of 0.4%.
U.S. imports rose 0.2% in July, smaller than estimates for a
In ADR news, GlaxoSmithKline (
) and Pfizer's (
) JV ViiV healthcare received FDA approval for Tivicay 50-mg
tablets. Tivicay is an integrase inhibitor indicated for use in
combination with other antiretroviral agents for the treatment of
HIV-1 in adults and children aged 12 years and older weighing at
least 40 kg (approx. 88 lbs).
The FTSE-100 was last up 0.57% at 6,611.94, the DAX up 0.68% at
8,415.76 and the CAC-40 up 0.51% at 4,092.50.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.